MICRO THERAPEUTICS
Micro Therapeutics provides invasive medical devices for the diagnosis and treatment of vascular diseases. It provides devices pertaining to the treatment of neurovascular disorders of the brain associated with stroke. It is also focused on the treatment of peripheral vascular disease, including blood clot therapy in hemodialysis access grafts, arteries, and veins. Its neurovascular product portfolio includes Sapphire and Sapphire NXT detachable coils that were developed to treat brain ane... urysms; Onyx, which is a liquid embolic that was developed to treat brain aneurysms and arterial-venous malformations; and delivery products, including guidewires, balloon catheters, and micro catheters, and more. It also provides a mechanical thrombolytic device for interventional clot disruption and dissolution. Micro Therapeutics was established in 1968, based in Irvine, California. It delivers its products to radiologists and neuroradiologists primarily in the United States, Canada, the European Union, and Japan. Micro Therapeutics currently operates as a subsidiary of Covidien plc.
MICRO THERAPEUTICS
Industry:
Health Care Health Diagnostics Medical Therapeutics
Founded:
1968-01-01
Address:
Irvine, California, United States
Country:
United States
Status:
Active
Similar Organizations
Advanced vascular Therapies
Advanced vascular Therapies provides non-invasive choices to individuals with poor circulation.
Medtronic
Medtronic develops and manufactures medical device technologies and therapies to treat chronic diseases worldwide.
Metabolic Testing Services
MET-TEST offers a higher level of diagnostic insight to improve management of cardiac and pulmonary diseases.
MRI Robotics
MRI Robotics is dedicated to advanced medical devices for the diagnosis and treatment of cancer.
Target Therapeutics
Target Therapeutics develops disposable medical devices for use in minimally-invasive procedures that are used to treat vascular diseases.
Transmural Systems
Transmural Systems is a medical devices company with a platform of percutaneous structural heart therapies for cardiovascular diseases.
Zerusa
Zerusa Limited designs, develops and markets minimally invasive medical devises for the diagnosis and treatment of vascular disease.
Founder
Stock Details
More informations about "Micro Therapeutics"
Micro Therapeutics - Crunchbase Company Profile & Funding
Micro Therapeutics was established in 1968, based in Irvine, California. It delivers its products to radiologists and neuroradiologists primarily in the United States, Canada, the European Union, and Japan. Micro Therapeutics currently operates as a subsidiary of Covidien plc.See details»
Micro Therapeutics - Funding, Financials, Valuation & Investors
Feb 18, 1997 · Micro Therapeutics provides invasive medical devices for the diagnosis and treatment of vascular diseases.See details»
Micro Therapeutic Research Labs
Micro Therapeutic Research Labs Pvt. Ltd (MTRL) is a full service Clinical Research Organization (CRO) based in Chennai, Tamilnadu. MTRL specializes in providing …See details»
Therapeutic advances of miRNAs: A preclinical and clinical update
Feb 1, 2021 · Mirna Therapeutics is a pioneer in capitalizing on the emerging field of miRNA-based therapeutics and their clinical trials. They are performing phase 1 clinical trial for …See details»
Micro Therapeutic Research - referral | European Medicines …
Micro Therapeutic Research Labs is a contract research organisation (CRO) which conducts the analytical and clinical parts of bioequivalence studies, some of which are used to support …See details»
Unlocking the promise of mRNA therapeutics - Nature
Nov 3, 2022 · The extraordinary success of mRNA vaccines against coronavirus disease 2019 (COVID-19) has renewed interest in mRNA as a means of delivering therapeutic proteins.See details»
Developing MicroRNA Therapeutics | Circulation …
Feb 3, 2012 · Three such companies (miRagen Therapeutics, Regulus Therapeutics, and Mirna Therapeutics), all of which were founded in 2007, have identified various miRNAs that play a role in different disease states and are …See details»
MicroRNA therapeutics: towards a new era for the management of …
Feb 17, 2017 · This Review discusses the role of different miRNAs in cancer and other diseases, and provides an overview of current miRNA therapeutics in the clinic.See details»
From micro to nano: evolution and impact of drug delivery in …
Current drug delivery innovations feature ambitious efforts to deliver large macromolecules to specific disease locations on timelines generally thought impossible. The developments of …See details»
MicroRNA therapeutics: principles, expectations, and challenges
MicroRNAs (miRNAs) are small stretches of non-coding RNA molecules that negatively regulate gene expression and are implicated in several cellular processes including cell proliferation …See details»
MicroRNA: trends in clinical trials of cancer diagnosis and therapy ...
Jul 10, 2023 · MiRNAs have been the focus of research given their potential clinical applications as therapeutic targets. Currently, various oncology clinical trials using miRNAs in screening, …See details»
Emerging concepts of miRNA therapeutics: from cells to clinic
Mar 16, 2022 · MicroRNAs (miRNAs) are very powerful genetic regulators, as evidenced by the fact that a single miRNA can direct entire cellular pathways via interacting with a broad …See details»
Multi-Organ Microphysiological Systems for Drug Development: …
More organ models, in addition to the liver and cancer, have been integrated into MOM systems to simultaneously evaluate the efficacy and toxicity of anti-cancer therapeutics. Two heart-liver …See details»
Nano- and Micro-Platforms in Therapeutic Proteins Delivery for …
Sep 12, 2024 · Micro- and nano-particles-based drug delivery platforms are designed to solve those problems and enhance protein therapeutic efficacy. This review first summarizes the …See details»
microRNA Therapeutics in Cancer — An Emerging Concept
Jul 11, 2016 · In this review, we have focused on the roles of miRNAs in tumorigenesis, the miRNA-based therapeutic strategies currently being evaluated for use in cancer, and the …See details»
Nykode Therapeutics AS (VACBF) Q3 2024 Earnings Call Highlights ...
19 hours ago · Total Revenue: Approximately $700,000 in Q3 2024. R&D Revenue: $540,000 from agreements with Genentech and Regeneron. Employee Benefit Expenses: $8.2 million in …See details»
Therapeutic targeting of microRNAs: current status and future ...
Jul 11, 2014 · MicroRNAs (miRNAs) are evolutionarily conserved small non-coding RNAs that have crucial roles in regulating gene expression. Increasing evidence supports a role for …See details»
Nutcracker Therapeutics Presents Precision Biomanufacturing and …
3 days ago · EMERYVILLE, Calif., November 25, 2024--Nutcracker Therapeutics will introduce its CRDMO capabilities to provide scalable biomanufacturing services for RNA drug developers.See details»
A role for microfluidic systems in precision medicine
Jun 2, 2022 · Here, we review past applications of microfluidic systems for precision medicine and discuss the present and potential future role of functional microfluidic assays as treatment …See details»
Emerging self-regulated micro/nano drug delivery devices: A step ...
Jun 1, 2021 · The convergence of mechanical/electronic techniques and micro/nanotechnology enables to craft self-regulated micro/nanodevices possessing desired release profiles, which …See details»